What is Boulder Care?
Boulder Care offers a comprehensive telehealth addiction treatment program centered on kindness, respect, and unwavering support. Patients gain 24/7 secure access to a dedicated Care Team, comprising Clinicians for medical care and medication management, Care Advocates for coordination and navigation, and Certified Peer Recovery Specialists who share lived experiences. This integrated approach aims to improve health outcomes, enhance patient satisfaction, and ensure long-term retention in care, all while optimizing costs through value-based payment models. The company operates within the rapidly evolving digital health and substance use disorder treatment sectors.
How much funding has Boulder Care raised?
Boulder Care has raised a total of $81.5M across 3 funding rounds:
Series A
$10.5M
Series B
$36M
Series C
$35M
Series A (2020): $10.5M with participation from First Round Capital, Greycroft Partners, Tusk Venture Partners, and BoxGroup
Series B (2022): $36M led by Goodwater Capital, First Round Capital, Qiming Venture Partners, and Greycroft
Series C (2024): $35M supported by First Round Capital, Advance Venture Partners, and Qiming Venture Partners
Key Investors in Boulder Care
First Round Capital
First Round Capital is an early-stage venture capital firm that supports startups in their foundational stages, providing tailored programs and resources to help them build their products and find their first customers.
Greycroft Partners
Greycroft is a venture capital firm specializing in internet and mobile markets, leveraging its extensive network to help entrepreneurs build successful businesses and gain market visibility.
Advance Venture Partners
Advance Venture Partners is an evergreen venture capital firm focused on long-term investments in tech and tech-enabled companies, emphasizing capital efficiency and scalability in sectors like digital health.
What's next for Boulder Care?
With its recent Series C financing, Boulder Care is poised for accelerated growth and enhanced service delivery. The substantial capital injection, particularly the major strategic investment, will likely fuel further technological development, expansion into new markets, and the scaling of its care teams. This funding round, following previous Series A and B rounds, signals a maturing company ready to solidify its position as a leader in accessible, high-quality addiction treatment. The focus on value-based care suggests a strategic alignment with healthcare system reforms and a commitment to demonstrating measurable impact.
See full Boulder Care company page
